INDSWFTLAB Charts, Analysis and Tips

home > pharma-and-healthcare > pharmaceuticals > indswftlab

Technical Analysis

Technical Strength: 7 / 10
Indicator Analysis Signal (0 - 10) Chart
RSI (?) RSI is 81.2. According to RSI analysis, indswftlab is overbought. 3.0 INDSWFTLAB RSI Chart
MACD (?) MACD: 11.0 and Signal Line: 7.84. According to MACD analysis, indswftlab is technically strong. 8.0 INDSWFTLAB MACD Chart
Simple Moving Average (?) According to simple moving average analysis, indswftlab is in a strong uptrend. Major support levels are 52.7075, 42.062, 38.4815. 10.0 INDSWFTLAB Simple Moving Average Chart
Exponential Moving Average (?) According to exponential moving average analysis, indswftlab is in a strong uptrend. Major support levels are 58.05675, 46.73675, 39.37356. 10.0 INDSWFTLAB Exponential Moving Average Chart
Bollinger Bands (?) %b is 0.872. According to bollinger bands, indswftlab is technically strong. 7.0 INDSWFTLAB Bollinger Bands Chart
Fibonacci Retracement (?) According to fibonacci retracement, no levels identified. NA INDSWFTLAB Fibonacci Retracement Chart
Average True Range (?) ATR: 5.59 NA INDSWFTLAB Average True Range Chart
Average Directional Index (?) ADX is 57 which means INDSWFTLAB's trend is ending soon. NA INDSWFTLAB Average Directional Index Chart
Note: Technical Analysis updated at 7PM on every trading day.
End-of-Day Share Price - NSE
January 03, 2018
Open Price 79.35
High Price 83.8
Low Price 76.2
Close Price 77.8
Absolute Change -1.05
Percentage Change -1.33%
Weekly Change 5.35%
Monthly Change 105%
Yearly Change 120%
52-week high 83.9
52-week low 31.25
Corporate Actions
ExDate Purpose
September 18, 2014 Annual General Meeting
September 20, 2011 AGM/DIV-RE.1/- PER SHARE
See all Corporate Actions
Volume Chart
Real time prices can be delayed by 20 minutes. Prices are refreshed from our server automatically after 1 minute. If NSE real time price is not available then BSE real time prices are provided. Volume displayed might not be correct..

Fundamental Analysis

Beta (?)1.14
Confidence in Beta2.66%
Market Capital Rs. 318.0 Cr
Diluted Trailing Twelve Months (TTM) Earnings Per Share (EPS) Rs. -14.37
TTM Price-to-Earnings (P/E) Ratio 0
Whenever available, consolidated financial results are used. For details, see here.
Stock Deliverable Quantity and Daily Volatility
Indicator Analysis Signal (0 - Strong Sell, 10 - Strong Buy) Chart
Deliverable Quantity (?) 03 January 2018: Deliverable Quantity:9.49e+04 NA INDSWFTLAB Deliverable Quantity Chart
Annualized Daily Volatility (Spot Price) (?) 03 January 2018: Daily Volatility:1.3545 NA INDSWFTLAB Annualized Daily Volatility (Spot Price) Chart


December 13, 2017 Disclosure under SEBI Takeover Regulations Essix Biosciences Limited has informed the Exchange that a copy of disclosure under Regulation 10(6) in respect of acquisition under Regulation 10 of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.
November 15, 2017 Updates Ind-Swift Laboratories Limited has informed the Exchange regarding 'Regarding declaration of Financial Results for the quarter ended 30th September, 2017.'.
See all Announcements

Board Meetings

Date Meeting Date Purpose
December 01, 2017 December 14, 2017 Results to consider inter alia among other items, the Un-audited Financial Results for the quarter and half year ended September 30, 2017.
September 05, 2017 September 14, 2017 Results To consider inter-alia among other items, the Un-Audited Financial Results for the quarter ended June 30, 2017
See all Board Meetings

Intraday Pivot Points

S3 S2 S1 Pivot R1 R2 R3
Rs. 67.13 Rs. 71.67 Rs. 74.73 Rs. 79.27 Rs. 82.33 Rs. 86.87 Rs. 89.93